New cases tested for RR-/MDR-TB (%) in Romania
Romania: New cases tested for RR-/MDR-TB was 76.0% in 2024. ▲ Rising
New cases tested for RR-/MDR-TB in Romania, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, new cases tested for rr-/mdr-tb in Romania stood at 76.0%.
Compared with earlier readings it is down 2.6% on the previous year and up 4.1% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Romania peaked at 91.0% in 2018 and was at its lowest, 13.0%, in 2005.
Romania ranks 133rd of 192 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 19 years of available data.
New cases tested for RR-/MDR-TB in Romania, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 13.0% | — |
| 2007 | 23.0% | +76.9% |
| 2008 | 30.0% | +30.4% |
| 2009 | 34.0% | +13.3% |
| 2010 | 38.0% | +11.8% |
| 2011 | 42.0% | +10.5% |
| 2012 | 43.0% | +2.4% |
| 2013 | 59.0% | +37.2% |
| 2014 | 73.0% | +23.7% |
| 2015 | 82.0% | +12.3% |
| 2016 | 85.0% | +3.7% |
| 2017 | 87.0% | +2.4% |
| 2018 | 91.0% | +4.6% |
| 2019 | 89.0% | -2.2% |
| 2020 | 84.0% | -5.6% |
| 2021 | 89.0% | +6.0% |
| 2022 | 87.0% | -2.2% |
| 2023 | 78.0% | -10.3% |
| 2024 | 76.0% | -2.6% |
Romania compared with similar countries
- Romania's 76.0% is below the median for high income countries, which is 91.0%, 84% of the median. (64 countries reporting)
- Romania's 76.0% is below the median for Europe & Central Asia, which is 91.0%, 84% of the median. (49 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in Romania changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | +76.9% | 13.0% | 23.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.0% | 13.0% | 34.0% | 4 |
| 2010s | 68.9% | 38.0% | 91.0% | 10 |
| 2020s | 82.8% | 76.0% | 89.0% | 5 |
Countries ranked near Romania
More health data for Romania
- Un projection of annual infant deaths, annual growth rate -2.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0845 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,419 deaths per 1,000 people (2090)
- Number of infants who die before age 1 113 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0235 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Romania?
- New cases tested for rr-/mdr-tb in Romania was 76.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Romania?
- The highest recorded value was 91.0% in 2018.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Romania?
- The lowest recorded value was 13.0% in 2005.
- How does Romania rank for new cases tested for rr-/mdr-tb?
- Romania ranks 133rd out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Romania?
- Over the last ten years it is up 4.1%. The long-run trend across the full record is rising.
- Where does this Romania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).